Hints and tips:
Related Special Reports
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...Merck said the deal would strengthen the company’s position in the fast-growing field of immunology, where there is significant unmet patient need....
...But the treatment could reward persistence in a field dogged by failure....
...Baras said the GLP-1 drugs from Novo Nordisk and Eli Lilly had been a “fantastic development for the field”....
...The clinical trial forms part of a six-year collaboration between Merck and Moderna in the field of developing personalised cancer vaccines....
...Johnson & Johnson thinks there is money to be made in the cardiovascular field....
...“It’s incredible the number of fields in which you can apply it,” he said....
...Startups like Delix Therapeutics, and Empath Ventures are also busy in the field. The illegality of most psychedelics is one obstacle....
...The “amyloid hypothesis” — the idea that clearing the plaques will improve the condition — has dominated the field for more than two decades, despite previous amyloid-busting drugs failing to show their...
...China is conducting more clinical trials in the Car-T field than any other country, with 492 registered studies, compared with 362 in the US and 274 in Europe, according to a database compiled by Beacon...
...In China, start-up companies in the field of drug discovery are emerging one after another, dovetailing with a push by the administration of President Xi Jinping to advance China’s pharmaceutical industry...
...Now They Feel Robbed (“Worldcoin CEO Alex Blania acknowledged that people are upset, but said the company is learning through its field testing.”)...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...company is well placed to succeed: it bought mRNA start-up Translate Bio for $3bn earlier this year, and has promised to plough €400m a year into mRNA vaccine research with 400 scientists working in the field...
...Write to the FintechFT team at imani.moise@ft.com and sid.v@ft.com....
...Apple has attempted to make some inroads, for example partnering with Johnson & Johnson, the pharmaceutical group, to study how its watch can reduce the risk of stroke....
...It is a field that has dwindling supply and demand, but there is every name a collector would want: Monet, Degas and Renoir feature, plus three works by Vincent van Gogh....
...Other companies in the Covid antibody field include Eli Lilly, GlaxoSmithKline and Celltrion....
...There was a March release date given for Gran Turismo 7 and the unfortunate slippage of Grand Theft Auto V from November to March. Axios has more....
...The approval of Biogen’s Alzheimer’s drug has reignited investor interest in a contested hypothesis about what causes the disease, despite years of failures in the field and staunch dismissal of the theory...
...Shares in Vectura, whose clients include GlaxoSmithKline and Hikma Pharmaceuticals, closed up 14 per cent at 155p....
...The pharmaceutical industry is eagerly awaiting the US regulator’s decision on a potential blockbuster Alzheimer’s drug....
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...Michel Vounatsos, chief executive of Biogen, said: “This historic moment is the culmination of more than a decade of groundbreaking research in the complex field of Alzheimer’s disease.”...
...It contains an artificially produced recombinant protein, a common basis for many pharmaceuticals, which is derived from coronavirus....
International Edition